AVITA Medical, Inc. (AVH)
Market Closed
CXA CXA Primary 
XSTU 337.95M Market Cap
- P/E Ratio
0% Div Yield
40,493 Volume
- Eps
Summary
AVH closed today lower, a decrease of 1.5% from yesterday's close, completing a monthly decrease of -41.12%. Over the past 12 months, AVH stock lost -37.67%.
AVH is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on CXA (AUD).
Want to track AVH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AVITA Medical, Inc. Dividends
AVH is not paying dividends to its shareholders.
AVITA Medical, Inc. Earnings
AVH have yet to publish their earning reports.
AVH is not paying dividends to its shareholders.
AVH have yet to publish their earning reports.
AVITA Medical, Inc. (AVH) FAQ
On which exchange is it traded?
AVITA Medical, Inc. is listed on CXA.
What is its stock symbol?
The ticker symbol is AVH.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 337.95M.
Has AVITA Medical, Inc. ever had a stock split?
No, there has never been a stock split.
AVITA Medical, Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Mr. James M. Corbett CEO | CXA Exchange | - ISIN |
| US Country | 260 Employees | - Last Dividend | 24 Jun 2020 Last Split | - IPO Date |
Overview
AVITA Medical, Inc., together with its subsidiaries, functions within the regenerative medicine realm on an international scale, with a focus on the United States. Initially known as AVITA Therapeutics, Inc., the entity underwent a name change, establishing itself as AVITA Medical, Inc. in 2020. The company has firmly rooted its headquarters in Valencia, California. It specializes in providing innovative medical devices and solutions, primarily catering to the treatment of various skin conditions and wounds through regeneration and repair mechanisms.
Products and Services
AVITA Medical, Inc. is at the forefront of regenerative medicine with its pioneering products:
- RECELL System - This flagship product stands as a groundbreaking cell harvesting device designed for the treatment of thermal burn wounds and full-thickness skin defects. It offers a unique approach to skin regeneration, allowing for the repigmentation of stable depigmented vitiligo lesions. The RECELL System encapsulates the company’s commitment to enhancing the healing process and improving patient outcomes through innovative technology.
- RECELL GO - As an extension of their product line, AVITA Medical is currently developing the RECELL GO, which seeks to streamline and control the manual processes involved in cell disaggregation, filtration, and soak time. This product is aimed at making the application of regenerative medicine more efficient and effective, thereby broadening the scope of treatments AVITA Medical can offer to its patients.
Contact Information
Address: 28159 Avenue Stanford
Phone: 661 367 9170
Website: https://www.avitamedical.com
2025 © Marketlog. All Rights Reserved.
